secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0000950170-24-127038
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences regains Nasdaq compliance as stock price holds above $1.00
------------------------------------------------------------------------------

- Received Nasdaq Staff letter on Nov 13, 2024 confirming regained compliance.
- Closing bid price was $1.00 or greater for 10 consecutive business days through Nov 13.
- Now compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
- Resolves prior deficiency; no further action required from the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/0000950170-24-127038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/kzr-20241113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-127038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer